Switzerland · pharma & laboratory
Pharmaceutical and Biotech Refrigeration in Switzerland
Swiss projects skew toward high-value, lower-volume storage: laboratory and biobank cooling, clinical trial material, cell and gene therapy, and manufacturer storage on constrained urban campuses. Specification depth and reliability outrank price in most Swiss bid evaluations, and the cost base reflects it.
Direct answers for project buyers
Pharmaceutical cold storage in Switzerland is typically high-specification and modest in area: validated +2/+8 °C suites, −20 °C and −80 °C laboratory and biobank capacity on constrained campus sites, planned around a roughly 30–33 °C summer design condition in the lowlands, high installation cost and redundancy expectations that frequently exceed N+1.
The market in context
Planning parameters
- Summer ambient design
- ≈ 30–33 °C dry bulb in the lowlands; lower at altitude
- Electricity (commercial, indicative)
- ≈ CHF 0.15–0.28 / kWh
- Typical bands
- +2/+8 °C, −20 °C, −70/−80 °C, LN₂ vapour phase for cell & gene material
- Dominant project type
- Laboratory, biobank and clinical trial storage; campus manufacturer suites
- Redundancy norm
- N+1 as a floor; 2N or spare-unit strategies on irreplaceable material
- Site constraint
- Plant-room space and installation windows often decide the solution
Direct answers for project buyers
How do you plan cooling for a Swiss biobank?
Start from the failure case, not the capacity: how long can the material tolerate an excursion, what happens if a unit fails at 02:00, where does material go, and who is alerted. Those answers determine spare-unit ratio, backup injection, generator and monitoring architecture. Capacity sizing is then straightforward by comparison.
Why is heat rejection often the hard part on Swiss campus sites?
Because roof space, noise limits and neighbour constraints restrict condenser placement, and poor condensing conditions penalise ULT plant heavily. Resolving the heat-rejection location and its noise limits early usually saves more than any equipment selection decision made later.
How should Swiss buyers compare suppliers?
On documented part-load efficiency, service response time with a named local capability, spare-parts availability, monitoring integration and the completeness of the validation package — then on ten-year total cost of ownership. Purchase price is rarely the deciding factor on Swiss projects and should not be treated as one.
Typical project scale
- Laboratory / biobank cooling: 10–60 ULT units or a small ULT room
- Campus validated suite: 50–400 m²
- Manufacturer storage: 400–2,000 m² multi-band
How this project is usually structured
- 1Switzerland
- 2Biotech / laboratory / biobank
- 3−20 °C and −70/−80 °C plus +2/+8 °C
- 4High-redundancy plant, backup injection, independent monitoring
- 5Cooling load → redundancy planner → TCO
- 6Structured pharmaceutical RFQ
Tools for this project
How ColdMatch Group works — independent B2B procurement and sourcing platform — ColdMatch Group is an independent B2B procurement and sourcing platform for industrial refrigeration, cold storage and cold-chain projects from USD $250K+, connecting buyers with qualified third-party suppliers, EPC contractors and independent financing providers.
References
ColdMatch Group is a B2B procurement platform. It provides planning tools and connects project buyers with relevant manufacturers and solution providers. It is not a manufacturer, engineering contractor, validation consultant or certification body, and nothing on this page is regulatory or validation advice.